GYD-84344-09138
2 vaccinations
1 coded response
3 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 395 / MS
- Registered
- 2021-08-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-08-01
Dose 1 — Moderna
-
2021-08-30
Registered in v-safe
-
2021-08-30
Dose 2 — Moderna
-
2021-08-31
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-09-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2022-08-30
Survey response — 12 months, dose 2MedDRA: Thyroid cancer — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · HospitalizationFree text: Thyroid cancerMedDRA releases: 2024-11 · check-in free text available
-
2022-08-30
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
- 2022-08-31
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-01 | Moderna | No |
| 2 | 2021-08-30 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 — 12 months, dose 2
Symptoms: Thyroid cancer
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Thyroid cancer | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release